Drug Shortage Report for LORAZEPAM INJECTION USP
Report ID | 156638 |
Drug Identification Number | 02243278 |
Brand name | LORAZEPAM INJECTION USP |
Common or Proper name | LORAZEPAM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION LIQUID |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIVI |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-09-19 |
Actual start date | 2022-09-19 |
Estimated end date | 2022-12-23 |
Actual end date | 2022-12-21 |
Shortage status | Resolved |
Updated date | 2022-12-28 |
Company comments | Inventory is available at Wholesalers on Allocation (100% of Historical demand). Allocation to remain in place until June 2023. |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v43 | 2022-12-28 | French | Compare |
v42 | 2022-12-28 | English | Compare |
v41 | 2022-12-12 | French | Compare |
v40 | 2022-12-12 | English | Compare |
v39 | 2022-12-12 | French | Compare |
v38 | 2022-12-12 | English | Compare |
v37 | 2022-11-16 | French | Compare |
v36 | 2022-11-16 | English | Compare |
v35 | 2022-10-04 | French | Compare |
v34 | 2022-10-04 | English | Compare |
v33 | 2022-09-22 | English | Compare |
v32 | 2022-09-21 | French | Compare |
v31 | 2022-09-21 | English | Compare |
v30 | 2022-09-21 | French | Compare |
v29 | 2022-09-21 | English | Compare |
v28 | 2022-09-21 | French | Compare |
v27 | 2022-09-21 | English | Compare |
v26 | 2022-09-20 | English | Compare |
v25 | 2022-08-19 | French | Compare |
v24 | 2022-08-19 | English | Compare |